H.R. 3, Elijah E. Cummings Lower Cost Drugs Now Act
H.R. 19, Lower Costs, More Cures Act
S. 2164, Lower Costs, More Cures Act of 2021
Drug cost and pricing policy issues
Patient affordability issues
Policy proposals relating to clinical trial diversity
Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2021 & 2022; Notice Requirement for Non-Federal Governmental Plans proposed rule Policy Proposals related to Medicare Part D and patient cost-sharing
Department of Health and Human Services (HHS) drug policy issues and regulatory policy issues
Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements (CMS 2482-F) Public Law 115-97 (formerly known as H.R. 1, Tax Cuts and Jobs Act) Implementation 
Policy proposals relating to economic activity in Puerto Rico
International tax issues, including OECD digital taxation work program Patent litigation reform issues and issues related to post-grant proceedings at the USPTO
Value of intellectual property
HCR - Health Issues MMM - Medicare/Medicaid TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 41 - Treasury, Dept of 12 - White House Office 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 41 - Treasury, Dept of 12 - White House Office 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 41 - Treasury, Dept of 12 - White House Office 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 41 - Treasury, Dept of 12 - White House Office
ABBVIE, INC.
1399 New York Avenue NW, Suite 600, Washington, DC, 20005, US
STEPHEN SCANGO DANIEL BACHNER DORCAS ADEKUNLE CRYSTAL RILEY STEPHEN SCANGO DANIEL BACHNER DORCAS ADEKUNLE CRYSTAL RILEY DANIEL BACHNER STEPHEN SCANGO DORCAS ADEKUNLE CRYSTAL RILEY DANIEL BACHNER STEPHEN SCANGO DORCAS ADEKUNLE CRYSTAL RILEY